73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers leverage cell self-destruction to treat brain tumors

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th

Researchers leverage cell self-destruction to treat brain tumors

by University of North Carolina Health CareAn MRI showing glioblastoma pre- and post-operation. Credit: Dominique Higgins, MD, PhDGlioblastoma is the most common type of brain tumor in adults. Th
Five things to do in your 20s and 30s to reduce your risk of preventable cancer

Five things to do in your 20s and 30s to reduce your risk of preventable cancer

by Sarah Allinson,The ConversationCredit: AI-generated imageMost of us don't think about cancer when we're in our 20s and 30s. But recent research has shown that people born after 1990 a

Five things to do in your 20s and 30s to reduce your risk of preventable cancer

by Sarah Allinson,The ConversationCredit: AI-generated imageMost of us don't think about cancer when we're in our 20s and 30s. But recent research has shown that people born after 1990 a
FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T

FDA approves first CAR T-cell therapy for adults with leukemia or lymphoma

by Lori SolomonThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T
Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-

Aumolertinib shows improved progression-free survival in stage III non-small cell lung cancer

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe epidermal growth factor receptor tyrosine kinase inhibitor aumolertinib demonstrated improved progression-
Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat

Clonal hematopoiesis may be more common among pediatric cancer survivors than the general population

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainResearchers identified a higher rate of clonal hematopoiesis (CH) and prevalence of treatment-induced STAT3 gene mutat
Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC

Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC

by European Society for Medical OncologyCredit: © European Society for Medical OncologyFirst-line osimertinib significantly lengthens overall survival compared to older generation EGFR-TKIs in pa

Front-line osimertinib improves overall survival in EGFR-mutation positive NSCLC

by European Society for Medical OncologyCredit: © European Society for Medical OncologyFirst-line osimertinib significantly lengthens overall survival compared to older generation EGFR-TKIs in pa
Biology behind new drug used to treat triple-negative breast cancer uncovered

Biology behind new drug used to treat triple-negative breast cancer uncovered

by Georgetown University Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainHow TTP488 (azeliragon), an experimental drug, impairs aggr

Biology behind new drug used to treat triple-negative breast cancer uncovered

by Georgetown University Medical CenterMammograms showing a normal breast (left) and a breast with cancer (right). Credit: Public DomainHow TTP488 (azeliragon), an experimental drug, impairs aggr
Research confirms unique danger of postpartum breast cancers

Research confirms unique danger of postpartum breast cancers

by Joe Rojas-Burke,Oregon Health & Science UniversitySites of Metastasis by Estrogen Receptor (ER) Status and Time Since Recent Childbirth Group. Analyses included a total of 1787 known meta

Research confirms unique danger of postpartum breast cancers

by Joe Rojas-Burke,Oregon Health & Science UniversitySites of Metastasis by Estrogen Receptor (ER) Status and Time Since Recent Childbirth Group. Analyses included a total of 1787 known meta
Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve

Re-engineering cancerous tumors to self-destruct and kill drug-resistant cells

byPennsylvania State UniversityCredit: Unsplash/CC0 Public DomainTreating cancer can sometimes feel like a game of Whac-A-Mole. The disease can become resistant to treatment, and clinicians neve
A way to prevent pancreatic cancer from spreading post-surgery?

A way to prevent pancreatic cancer from spreading post-surgery?

by Cold Spring Harbor LaboratoryOn the left is a section of a pancreatic cancer patient's primary tumor, with cancer cells (red) and CK19, a marker of proliferation (green), evident. On the r

A way to prevent pancreatic cancer from spreading post-surgery?

by Cold Spring Harbor LaboratoryOn the left is a section of a pancreatic cancer patient's primary tumor, with cancer cells (red) and CK19, a marker of proliferation (green), evident. On the r
Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

by Karolinska InstitutetCredit:New England Journal of Medicine(2024). DOI: 10.1056/NEJMoa2313487It is possible to leave most of the lymph nodes in the armpit, even if one or two of th

Clinical trial: Less extensive breast cancer surgery results in fewer swollen arms

by Karolinska InstitutetCredit:New England Journal of Medicine(2024). DOI: 10.1056/NEJMoa2313487It is possible to leave most of the lymph nodes in the armpit, even if one or two of th
Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainMetastatic or leptomeningeal disease (LMD), the spreading of a brain cancer to the meninges, is a devastating cancer complicat

Safety and efficacy of intraventicular immunovirotherapy with oncolytic HSV-1 for CNS cancers

byBrigham and Women's HospitalCredit: Unsplash/CC0 Public DomainMetastatic or leptomeningeal disease (LMD), the spreading of a brain cancer to the meninges, is a devastating cancer complicat